According to IMARC Group’s latest report, titled “Extracorporeal Membrane Oxygenation Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global extracorporeal membrane oxygenation machine market is expected to exhibit a CAGR of 5.3% during 2022-2027. Extracorporeal membrane oxygenation (ECMO) machine is a life support equipment that oxygenates red blood cells (RBCs) of patients suffering from prolonged cardiac and respiratory problems. It is extensively used when the heart and lungs cannot provide an adequate amount of gas exchange or perfusion that sustains life. The machine pumps out the blood to remove the carbon dioxide and sends back rewarmed, oxygen-filled blood back into the body. ECMO machine is usually applied in critical care situations to allow blood to bypass the heart and lungs, enabling the organs to rest and heal.
Request for a PDF sample of this report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsample
The global extracorporeal membrane oxygenation machine market is primarily driven by the increasing prevalence of respiratory infections and cardiovascular diseases and strokes. The rising awareness among individuals about the benefits of ECMO machines has also escalated its demand globally. Besides this, these machines are increasingly being used for patients who are more susceptible to chronic medical ailments like coronavirus disease (COVID-19) and acute respiratory distress syndrome (ARDS). Furthermore, the rising number of tobacco smokers, the growing geriatric population and the newborns suffering from respiratory diseases due to congenital disabilities and trauma are some of the other factors that are significantly influencing the market growth. Looking forward, IMARC Group expects the global extracorporeal membrane oxygenation machine market to continue its robust growth during the forecast period (2022-2027).
Checkout Now: https://www.imarcgroup.com/checkout?id=3805&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Abbott Laboratories
- ALung Technologies Inc.
- Braile Biomedical
- Eurosets, LivaNova PLC
- MicroPort Scientific Corporation
- Nipro Medical Corporation
- Origen Biomedical, Inc.
- Terumo Corporation
- Xenios AG.
Breakup by Component:
Breakup by Modality:
Breakup by Patient Type:
Breakup by Application:
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800